Key Financial’s MiNK Therapeutics INKT Stock Holding History
Bought
Maintained
Sold
Other funds holding INKT
BS
Key Financial's INKT Position: Q3 2026 in Review
Key Financial held its MiNK Therapeutics (INKT) position steady in Q3 2026 at 4 shares worth $50. The position accounts for ﹤0.01% of the portfolio, ranked #1293.
Key Financial first reported a position in INKT in Q2 2023 and has held it in 13 quarters since. The position peaked at $90 in Q2 2023. 22 funds tracked by Wall St. Rank hold INKT as of Q3 2026.
- Key Financial held 4 shares of MiNK Therapeutics worth $50 as of Q3 2026.
- Key Financial left its MiNK Therapeutics share count unchanged in Q3 2026.
- MiNK Therapeutics made up ﹤0.01% of Key Financial's portfolio in Q3 2026, its #1293 holding.
- Key Financial first reported a position in MiNK Therapeutics in Q2 2023 and has held it in 13 quarters since.
- Key Financial's MiNK Therapeutics position peaked at $90 in Q2 2023.
- 22 funds tracked by Wall St. Rank held MiNK Therapeutics as of Q3 2026.
Based on Key Financial's 13F filing for Q3 2026, filed 2 Nov 2026.